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Abstract
Background: Multicentre randomised trials provide some of the key evidence underpinning healthcare practice
around the world. They are also hard work and generally expensive. Some of this work and expense are devoted to
sites that fail to recruit as many participants as expected. Methods to identify sites that will recruit to target would
be helpful.
Methods: We asked trial managers at the Centre for Healthcare Randomised Trials (CHaRT), University of Aberdeen
to predict whether a site would recruit to target. Predictions were made after a site initiation visit and were collected
on a form comprising a simple ‘Yes/No’ prediction and a reason for the prediction. We did not provide guidance as to
what trial managers might want to think about when making predictions.
After a minimum of eight months of recruitment at each site for which a prediction had been made, all trial mangers
in CHaRT were invited to a group discussion where predictions were presented together with sites’ actual recruitment
performance over that period. Individual trial managers reflected on their predictions and there was a general discussion
about predicting site recruitment. The prediction reasons from the forms and the content of the group discussion were
used to identify features linked to correct predictions of recruitment failure.
Results: Ten trial managers made predictions for 56 site visits recruiting to eight trials. Trial managers’ sensitivity was 82%
and their specificity was 32%, correctly identifying 65% of sites that would hit their recruitment target and 54% of those
that did not. Eight ‘red flags’ for recruitment failure were identified: previous poor site performance; slow approvals
process; strong staff/patient preferences; the site recruitment target; the trial protocol and its implementation at the
site; lack of staff engagement; lack of research experience among site staff; and busy site staff. We used these red
flags to develop a guided prediction form.
Conclusions: Trial managers’ unguided recruitment predictions were not bad but were not good enough for decision-
making. We have developed a modified prediction form that includes eight flags to consider before making a prediction.
We encourage anyone interested in contributing to its evaluation to contact us.
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Introduction
Multicentre randomised trials provide some of the key
evidence underpinning healthcare practice around the
world. They are also hard work and generally expensive.
Some of this work and expense is devoted to sites that
fail to recruit as many participants as expected or simply
fail to recruit at all. This contributes to the well-known
fact that many trials struggle to recruit participants. For
the UK National Institute of Health Research Health
Technology Assessment programme, a major public
funder of multicentre trials in the UK, around half of all
trials fail to recruit to target [1–3]. In the UK and else-
where, many trials are abandoned; a Swiss study of > 1000
trials (two-thirds sponsored by industry) found that 25%
were abandoned, chiefly because of recruitment problems,
administrative issues and running out of money [4]. A US
study of one academic medical centre found 260 trials
abandoned because of poor recruitment over a five-year
period at a cost of almost $1 million [5]. Even trials that
meet their overall recruitment target can have large re-
cruitment variations across sites. Recruitment across the
13 sites in UKCTOCS ranged from 19% of those eligible
to 33% [6]. In BeWEL, 98% of participants came from just
three of the five sites, despite the substantial amount of
time spent by the central trial team on the two other sites
[7]. This contributes to research waste [8] and is one rea-
son why recruitment is the top research methods priority
in the UK [9].
Site selection for multicentre trials is done in a variety of
ways but often relies on the investigators’ networks of col-
leagues or hospitals (often through NHS Research and
Development departments in the UK) putting themselves
forward. Not all of these sites will be suited to the trial’s
recruitment task. The problem is distinguishing those that
are from those that are not. There are some formal
questionnaire-based methods [10, 11] but these are
time-consuming and evidence that they are effective at
selecting sites that will go on to recruit to target is lacking.
The Estimating Site Performance (ESP) project aims to
see if it is possible to predict which sites will and will
not meet their recruitment targets. Its approach has
three components:
1. Minimise form-filling. We want to make use of the
knowledge, experience and instincts of those tasked
with setting-up sites: trial managers (TM).
2. Quantify the veracity of TMs’ knowledge,
experience and instincts.
3. Suggest ways in which TMs’ knowledge, experience
and instincts could be guided so as to improve
predictions.
In short, can TMs predict which sites are worth invest-
ing energy in and should the trial team believe them?
Methods
All TMs employed in the Centre for Healthcare
Randomised Trials (CHaRT), Aberdeen, Scotland, UK,
who were conducting site initiation visits (SIV) be-
tween 2014 and 2015, were invited to take part.
Participating TMs all received an information sheet
about ESP and signed a consent form. Each TM was
asked to predict the recruitment success of each site
they opened after having completed the SIV. Predictions
were collected on a form that comprised a ‘Yes/No’ an-
swer to whether the site would recruit to target and a
reason for the prediction (see Additional file 1). There
was no guidance on the form as to the sorts of things
that TMs might want to think about when making their
prediction, rather it was a simple unguided ‘Why?’ ques-
tion. The form also collected the number of years of trial
management experience the TM had, together with de-
tails of the trial and recruitment targets for the site.
TMs were invited to complete one form for each site
opened. Prediction forms were completed on paper and
placed in envelopes, which were sealed. The SIVs were
timed around the time that local approval for the study
was expected or given and before recruitment starting at
the site. Limited feasibility work was carried out in
participating trials in order to guide site selection and
progression to SIV.
After a minimum of eight months of recruitment at
each site for which a prediction had been made, all TMs
in CHaRT were invited to a group discussion where pre-
dictions were presented together with sites’ actual recruit-
ment performance over that period. Eight months was
chosen largely on the pragmatic grounds that we consid-
ered it a suitable minimum period for sites to have over-
come teething problems and to have established a good
and steady recruitment process. Individual TMs reflected
on their predictions and a general discussion about pre-
dicting sites’ recruitment performance and TMs’ ability
and basis for predictions followed. The group discussion
was audio recorded and transcribed verbatim.
Analysis
Quantitative data from the prediction form were entered
into IBM SPSS Statistics 25.0 for reporting of descriptives,
percentages and frequencies. Site recruitment targets were
recalculated to be pro rata for the duration of recruitment
by the time of the group discussion meeting, meaning all
predictions were judged against targets for the appropriate
period. If the recruitment target was a range, e.g. 1–2
patients per month, the lowest number in the range was
used. A site was deemed to have met its recruitment
target if it met or exceeded that target.
Positive and negative predictive values (PPV and NPV,
respectively), as well as sensitivity and specificity, were
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calculated for all TMs, TMs with < 2 years of experience
and TMs with ≥ 2 years or more experience. Two years
of experience was chosen arbitrarily as a reasonable
cut-off point for the time it takes a TM to have acquired
a range of relevant experience that allows him or her to
judge when sites may struggle with recruitment. For our
recruitment predictions, PPV and NPV, sensitivity and
specificity can be defined as:
 PPV: what is the chance that a site predicted to hit
its recruitment target will actually hit it?
 NPV: what is the chance that a site predicted to
miss its recruitment target will actually miss it?
 Sensitivity: what proportion of sites that hit their
recruitment target are identified as a ‘Yes, the site
will recruit to target’ by TMs?
 Specificity: what proportion of sites that miss their
recruitment target are identified as a ‘No, the site
will not recruit to target’ by TMs?
Both the reasons for predictions given on the predic-
tion forms themselves as well as the transcript of the
group discussion were included in our qualitative ana-
lysis although this analysis focused more on the predic-
tion forms than the group discussion. The reasons for
the prediction provided on the prediction form were
sorted into types of predictions according to the predic-
tion made (Yes/No) and the accuracy of the prediction
(Correct/Incorrect).
We wanted to develop a guided ‘Will this site recruit
to target?’ question or questions: in other words, ‘Will
this site recruit to target? Think about x, y and z when
making your prediction’. Our starting point was that
TMs’ unguided predictions might be adequate but that
guided ones may be better; the problem was what guid-
ance (the x, y and z) to give. The way this guidance
would be operationalised led us to think about what
might undermine recruitment success; in other words,
‘red flags’ that, if present, raise doubts about a site’s abil-
ity to recruit. Conventional content analysis [12] was
therefore done on correct negative predictions (the site
will not recruit to target) with the aim of identifying red
flags that triggered the correct negative prediction. We
also looked for clear signs of where the absence of a flag
supported recruitment success, especially from the
group discussion. This analysis was carried out post hoc.
Results
All 10 eligible TMs took part and made predictions for 56
site visits relating to eight trials. One additional prediction
form was completed that provided reasons for the predic-
tion but did not record the actual prediction itself. This
prediction form is therefore not included in our
quantitative analysis. Thirty-nine of the predictions were
made in connection with seven Phase III pragmatic rando-
mised trials recruiting adults. The SIVs were mainly con-
ducted face-to-face. The remaining 17 predictions came
from a single non-randomised study, which used a launch
meeting with a combination of other modes of SIVs (see
Table 1). For this study, the two TMs divided the 17 sites
between them for predictions (6 and 11 sites, respectively).
For the randomised trials, two TMs attended three of the
same SIVs and made separate predictions for the same
sites. In all cases, predictions were made independently
and without conferring with the other TM. Table 1 sum-
marises the types of SIV by trial.
For the group discussion, nine of the 10 TMs who had
made predictions attended; one was unable to. An
additional three TMs who had not made any predictions
also attended. Only quotes from TMs who made predi-
cations have been used here.
Predictions
The TMs’ predictions are presented in Tables 2, 3 and 4.
Out of the 56 predictions made, 35 (62%) were correct and
21 (38%) were incorrect. From Tables 2, 3 and 4 it is clear
that most predictions were ‘Yes’ (43/56, or 77%) and that
most of these predictions were correct (the 65% PPV). TMs
identified 82% (28/34) – their sensitivity – of all sites that
hit their targets.
There were fewer ‘No’ predictions (13/56, or 23%)
and seven of these were correct (the 54% NPV). TMs
identified 32% (7/22) – their specificity – of all sites
that missed their targets.
Experience made a difference for the PPV (the chance
a predicted ‘Yes’ is an actual ‘Yes’) and specificity (the
proportion of sites that did not recruit to target that
were correctly identified), which were both substantially
higher in the more experienced group of TMs, though
numbers in these subgroups were small. The NPV got
worse with experience although, again, numbers were
very small.
Exploration of the written justification for predictions
The content analysis of written predictions identified
eight distinct red flags linked to correct predictions of a
failure to recruit to target (Table 5). The red flags identi-
fied in these predictions are described below in no
particular order. They are numbered to guide the discus-
sion of the flags below.
1. Previous poor performance
Some TMs had either personal experience of working
with a site on other studies or the knowledge of site per-
formance on other studies was shared within the Trials
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Unit. Knowing a site has previously performed poorly led
to the expectation that this will happen on future trials.
‘Previous record for recruiting for previous CHaRT
trials has not been high (same PI).’ (TM-5, < 2 years of
experience, correct prediction of recruitment failure).
‘Previous experience with site on a study, they only
recruited one participant.’ (TM-6, ≥ 2 years of
experience, correct prediction of recruitment failure).
2. Slow/non-standard approval process
Although the overarching structure for approvals has
been streamlined in the UK, the approval process can still
vary considerably between individual sites as observed by
one TM here. If the approvals stage is slow, it will eat into
the time allocated to recruitment in the trial.
‘Prolonged R&D approval process with lots of people
required to sign off the study – very bureaucratic.’
(TM-1, ≥ 2 years of experience, correct prediction of
recruitment failure).
Reflections from the post-results group discussion also
highlighted that the way the approvals process in the UK
is timed and the way its ‘clocks’ start and stop can still
cause delays for a trial even if it does not formally show
up as approvals delay; the overall effect is still a delay to
recruitment start.
‘One site that just refused to take the document set for
two months because they had R&D issues and staffing
issues and they said, “We can’t do anything with this
but we are timed on this so we don’t want it don’t give
it to us”.’ (TM-5 < 2 years of experience).
3. Patient or staff preferences or beliefs
One TM was told by a principal investigator (PI) that
patients had a clear preference for a certain treatment. If
most patients do not want to be randomised, this signifi-
cantly limits the pool of potential participants available
to a trial at that site.
‘Appears, following discussion with PI at end of SIV
[site initiation visit], that a lot of patients favour
Table 1 Type of trial, associated trial managers (TM) and the type of site initiation visits (SIV) used
Trial ID Type of trial TMs making
predictions (n)
Type of SIV
Face-to-face Teleconference Teleconference, launch
meeting and other
Face-to-face, teleconference
and launch meeting
Total SIVs (n)
1 Non-RCT 2 0 0 13 4 17
2 RCT 1 1 0 0 0 1
3 RCT 1 3 0 0 0 3
4 RCT 1 6 1 0 0 7
5 RCT 1 3 1 0 0 4
6 RCT 2 15 0 0 0 15a
7 RCT 1 1 3 0 0 4
8 RCT 1 5 0 0 0 5
aThis number includes one visit where a prediction form was completed but the actual prediction was not recorded
RCT randomised controlled trial
Table 2 Predictions made by all trial managers
Actual Yes
(met target)
Actual No
(missed target)
Total
Predicted Yes 28 15 43
Predicted No 6 7 13
Total 34 22 56
Positive predictive
value (%)
65 Negative predictive
value (%)
54
Sensitivity (%) 82 Specificity (%) 32
Table 3 Predictions made by trial managers with < 2 years of
experience
Actual Yes
(met target)
Actual No
(missed target)
Total
Predicted Yes 7 8 15
Predicted No 1 2 3
Total 8 10 18
Positive predictive
value (%)
47 Negative predictive
value (%)
67
Sensitivity (%) 88 Specificity (%) 20
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[treatment A over treatment B]…’ (TM-5, < 2 years of
experience, correct prediction of recruitment failure).
Reflections from the post-results group discussion also
highlighted a lack of equipoise as a possible reason for
recruitment failure:
‘… and we were about halfway into it [the site visit], it
was just obvious he was not in equipoise, he was not
going to recruit to this trial… and lo and behold they
closed down about six months later.’ (TM-4, < 2 years
of experience).
4. Target for recruitment
How recruitment targets are decided varies between
trials and sites. Although a recruitment target is just a
number, that number has significance in that it will
affect motivation to recruit, especially if it is set un-
realistically high at the outset. Here, the research
nurse expressed doubt that the recruitment target for
the site was realistic. This realisation is demoralising
to the research nurse and likely to impact on their ef-
forts to recruit.
‘Research nurse…was doubtful about target
recruitment.’ (TM-6, ≥ 2 years of experience, correct
prediction of recruitment failure).
Reflections from the post-results group discussion also
highlighted that recruitment targets do not get much at-
tention at the early stages, are set artificially and for
some trials appear to have been set too low across sites.
‘Well with hindsight looking at the targets that are set
they were too low.’ (TM-9, ≥ 2 years of experience).
‘[…site name…] they done really well but did promise
a lot more. So their target was small, they did promise
that they had, you know, hundreds of people that they
could contact. So I mean although they did meet
prediction and they did recruit really, really well I still
would’ve expected more from them.’ (TM-8, < 2 years
of experience, reflecting on a correct prediction of
recruitment success).
Combining an incentive with the ‘per patient’ pay-
ment is, however, one way of encouraging sites to
reach their target.
‘…and [site] had an incentive because we said if they
got to 20 we’d pay for them to have a [name of
equipment], which is a piece of equipment they needed
for the study and we said if they didn’t reach 20 they’d
have to make a contribution to that piece of
equipment…And they reached 20 and stopped.’ (TM-
7, ≥ 2 years of experience, reflecting on a correct
prediction of recruitment success).
5. Problems with the trial protocol and/or its
implementation
The nature of a trial can make it more or less difficult
to recruit to across sites. Issues with the trial protocol
are likely to be generic across all sites, although the de-
gree to which it affects recruitment may vary depending
on a site’s capacity to work around the challenges the
protocol presents, particularly if this is at odds with the
local patient pathways. Here, a research nurse recog-
nised the trial as difficult to recruit to at the SIV. Trials
that are more difficult to recruit to place a higher
demand on the site team and this influences their en-
gagement with the trial.
‘RN [research nurse] did recognise it was a difficult
trial to recruit to…’ (TM-6, ≥ 2 years of experience,
correct prediction of recruitment failure).
Table 4 Predictions made by trial managers with ≥ 2 years or
more experience
Actual Yes
(met target)
Actual No
(missed target)
Total
Predicted Yes 21 7 28
Predicted No 5 5 10
Total 26 12 38
Positive predictive
value (%)
75 Negative predictive
value (%)
50
Sensitivity (%) 81 Specificity (%) 42
Table 5 An overview of the eight red flags identified in trial
managers’ correct predictions of a failure to recruit to target
Red flag
1 Previous poor performance
2 Slow/non-standard approval process
3 Patient or staff preferences or beliefs
4 Target for recruitment
5 Problems with the trial protocol and/or its implementation
6 Lack of engagement of site team
7 Lack of research experience of site staff/staff changes
8 Busy site staff
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Reflections from the post-results group discussion also
highlighted that a mismatch between the local care path-
way and the trial design can cause an issue:
‘And they just said “This is just not how things work
here, it’s just impossible to execute.” So you find out
these little gems when the PI isn’t around.’ (TM-2, ≥ 2
years of experience).
Sometimes, the way a site is physically set up, e.g.
split so that there are several hospitals that can
recruit to the trial but they are only counted as one
site, can cause delays in set-up, especially if the TM
is only made aware of this at the SIV. Here, the TM
notes that due to the site being split there would be
two pharmacies involved, which has implications for
the set-up process and can cause delays to recruit-
ment start.
‘Split site, two pharmacists involved.’ (TM-7, ≥ 2 years
of experience, correct prediction of recruitment failure).
Reflections from the post-results discussion also
highlighted site facilities as a reason for recruitment failure:
‘Like in [name of site]…, it turned out that they have a
massive [name of treatment] centre and they have no
surgery spaces for [name of alternative treatment] so
how can then they offer ... how can they randomise to
have the treatments and say that they’ll get the
treatments in eight weeks ... because they don’t have a
surgery space.’ (TM-6, ≥ 2 years of experience,
reflecting on correctly predicting recruitment failure).
An important function of the SIV is often that the
whole team is gathered and there is an opportunity
to plan how recruitment will work and distribute
responsibility for all the tasks involved. However, this
process works best if the parties involved have come
prepared. If the way recruitment is going to be done
cannot be agreed early, it is likely to cause delays to
recruitment start.
‘Lots of confused discussion between team about how
best to identify patients and recruit them.’ (TM-7, ≥ 2
years of experience, correct prediction of recruitment
failure).
‘Lots of problems and difficulties thrown at me at SIV
teleconference.’ (TM-1, ≥ 2 years of experience, correct
prediction of recruitment failure).
Whereas for successfully recruiting sites, this was one
of the main purposes of the SIV.
‘…Thought about recruitment in advance and have
identified PICs [Participant Identification Centres] …’
(TM-7, ≥ 2 years of experience, reflecting on correct
prediction of recruitment success).
‘The site have proactively pushed for teleconference to
arrange site training – were very engaged at the
teleconference and asked questions about approaching
patients. They had identified potential participants at
PI clinic before the teleconference…’ (TM-9, ≥ 2 years
of experience, reflecting on correct prediction of
recruitment success).
6. Lack of engagement of site team
The level of engagement of a site with the trial will
be evident to the TM throughout the set-up process
and usually before the SIV. Often the PI is essential
to recruitment of a trial as he or she will often be
the person who first introduces patients to the trial,
which may not happen if the PI is not fully engaged
with the trial.
‘PI only engaged in the study at a very late stage.’
(TM-1, ≥ 2 years of experience, correct prediction of
recruitment failure).
Reflections from the post-result group discussion
also highlighted that a PI’s engagement can vary over
the lifespan of the trial, highlighting that this is an
issue throughout.
‘[Site name], although recently the research nurse has
advised that she’s having issues with engagement from
the PI there. Again, looking back at the site initiation
as well there were some signs there, but again, initially
when they started recruiting they were recruiting quite
well and it’s just been the last few months that it’s sort
of slowed down… Lack of engagement with the PI, he’s
just stopped… there’s lack of communication with the
research nurse.’ (TM-5, < 2 years of experience,
reflecting on an incorrect prediction of recruitment
success).
The level of engagement of site team members can be
picked up in many ways, even body language at the SIV.
‘PI listened but seemed keen to have SIV over.’
(TM-10, ≥ 2 years of experience, correct prediction of
recruitment failure).
Conversely, good engagement supports recruitment:
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‘…PI has sent emails to R&D on her own initiative to
chase up R&D approval to allow site opening. …’
(TM-9, ≥ 2 years of experience, correct prediction of
recruitment success).
‘Very engaged team who have discussed early staffing
issues with us up-front and plan to work around this
in the long term.’ (TM-1, ≥ 2 years of experience,
correct prediction of recruitment success).
Reflections from the post-results discussion also illus-
trate how this kind of lack of engagement is a warning
sign of likely recruitment failure:
‘The PI was quite awkward I felt ... how did it work if he
saw a patient out in rural hospital, would they have to
come into the main hospital, how would the research
nurses know he’s seen a patient ... just lots and lots of ifs
and buts that I kind of should’ve flagged up more
warning signs at the start I think.’ (TM-7, ≥ 2 years of
experience, reflecting on an incorrect prediction of
recruitment success).
There is a lot of background work involved in plan-
ning and conducting SIVs; often many site team mem-
bers will be invited as it is important that they receive
the training relevant to the trial. If a member of the site
team does not attend the SIV, alternative arrangements
will have to be made, which again is likely to slow down
the trial progress at the site.
‘Other named consultant who will recruit did not
attend SIV.’ (TM-10, ≥ 2 years of experience, correct
prediction of recruitment failure).
Reflections from the post-results discussion also
highlighted lack of engagement with the SIV as a fac-
tor affecting recruitment success:
‘They’re just… I mean I said lots of problem… at their
site initiation visit there was just… the PI never came to
the investigator meeting, the site visit was a nightmare
to even organise.’ (TM-1, ≥ 2 years of experience,
reflecting on correctly predicting recruitment failure).
‘…but just half an hour of dedicated time for the
meeting would be good. … I don’t know whether really
it’s made any difference me coming here because I
don’t think they were listening. … And then when
people don’t attend, that’s the worst as well.’ (TM-2,
≥ 2 years of experience).
Throughout the lifespan of a trial there needs to be a
flow of communication between the trial office and sites
and if this flow is poor, then this will slow down the trial
at that site.
‘Email communication is slow.’ (TM-10, ≥ 2 years of
experience, correct prediction of recruitment failure).
Reflections from the post-results discussion also
highlighted this as a reason for recruitment failure:
‘[name of site] were always, they were just a bit cagey.’
(TM-10, ≥ 2 years of experience, reflecting on
correctly predicting recruitment failure).
Conversely, good communication supports recruitment:
'And I know in [trial] you know, the sites that have
probably done really, really good are the ones that we’ve
had that great communication with, the ones that picked
up the phone whenever there’s been the slightest query
and we’ve been able to deal with that really quickly and
then away we’ve went again… But I think yeah, to keep
that communication going is probably one of the key
things.’ (TM-7, ≥ 2 years of experience).
7. Lack of research experience of site staff and staff
changes
The lack of research experience of staff, for both PIs
and research nurses, was noted as a problem. Having
site staff without research experience is also likely to
slow down the trial at a site due to research-naïve staff
having to become familiar with the research process in
general as well as with the procedures involved for spe-
cific trials.
‘PI first time as PI; two other consultants relatively
research naïve.’ (TM-7, ≥ 2 years of experience,
correct prediction of recruitment failure).
‘The site is about to lose an experienced research
nurse and promote a nurse with no research
experience.’ (TM-10, ≥ 2 years of experience, correct
prediction of recruitment failure).
Reflections from the post-results discussion also
highlighted turnover of site staff as a factor affecting
recruitment success:
‘[name of site] I think have had quite a few changes
of staff so that might explain quite a lot of those
issues.’ (TM-4, < 2 years of experience, reflecting on
an incorrect prediction of recruitment success).
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Although the discussion also highlighted that there are
exceptions.
‘Well yeah, there’s almost a complete turnover in
people at [name of site], but they have been good. The
new guy’s brilliant … Well yeah, they’ve got, well
everyone who was at the site visit is no longer there.’
(TM-10, ≥ 2 years of experience, reflecting on an
incorrect prediction of recruitment failure).
8. Busy site staff
Often a site is involved in multiple trials and if a TM
knows the site staff have a high team workload there is
an anticipation that their trial may not be prioritised by
busy site staff.
‘[name of research nurse] but she has many studies to
deal with.’ (TM-10, ≥ 2 years of experience, correct
prediction of recruitment failure).
Reflections from the post-results group discussion also
highlighted this as a reason for recruitment failure:
‘Well looking back now at the site initiation the PI was
very busy, she had just come off a nightshift and she
was wanting to do everything. So thinking back now in
retrospect there was warning signs then.’ (TM-5, < 2
years of experience, reflecting on an incorrect
prediction of recruitment success).
‘…and they have no support currently at all. They’re
taking the projects on because they want them on the
books, but they have absolutely no network to support
it…’ (TM-2, ≥ 2 years of experience).
Discussion
Trials are hard work and we want that work to be worth
it. Investing substantial amounts of work in trial sites
that fail to recruit is something to try and avoid because
there is plenty of work to do elsewhere in the trial. Some
work has been done with site selection questionnaires
[10, 11] but we wanted to see if something simpler was
both possible and useful with regard to likely recruit-
ment success: asking the TMs setting up the site what
they thought.
We asked TMs to make simple Yes/No predictions
and we gave no guidance as to what they should think
about when making their predictions. Ten TMs made 56
predictions across eight trials and it turns out that TMs
are pretty good at making these predictions. If we think
of TMs as a diagnostic test of recruitment, our TMs had
a sensitivity of 82% and a specificity of 32%, correctly
identifying 65% of sites that would hit their recruitment
target and 54% of those that did not.
The 32% specificity is the critical feature of this
diagnostic test and it is very low. As mentioned in
the ‘Analysis’ section, we were particularly interested
in sites that were predicted to be poor recruiters be-
cause these consume a substantial amount of trial
management time and resource for little return. A
specificity of 32% is too low to take decisive action
based on a poor recruitment prediction. It seems pre-
mature, for example, to recommend rejection of sites
predicted to be poor recruiters or stopping the sup-
port given to them.
We expected this and the work described here was
always intended as the first stage of our ESP work. This is
why we also looked for ‘red flags’—factors associated with
recruitment failure—because we suggest that these can be
used to provide guidance to TMs when thinking about their
recruitment predictions. Table 5 shows the eight red flags
we identified in our qualitative work. We anticipate that the
more red flags that are identified during site-set-up, the
more likely it will be that a TM would be justified in mak-
ing a ‘No’ prediction.
It is clear that there is some overlap between flags
and that some may well be more important than
others. We do not think the flags should be a simple
box-ticking exercise but be used as a prompt for dis-
cussion when doing a SIV. Discussion of the flags
after the visit by the central trial team could support
decisions about which sites will need more support,
which less and whether poor recruitment expectations
at some sites means new sites are needed. Some
could also be considered before the SIV. In particular,
previous poor performance, the recruitment target,
problems with the trial protocol and/or its implemen-
tation and lack of research experience of site staff/
staff changes could be considered early on in site
identification and set-up. We did not use the predic-
tions to influence trial conduct in the work described
in this paper, but it is easy to imagine that ticks
against these red flags well before the SIV could give
the central trial team reason to reconsider whether
the site was worth pursuing. At the very least, the
site might fall down the order list of which sites are
brought on-stream or perhaps a member of the team
could do a ‘site selection visit’ (in person or by tele-
conference) to confirm whether it was worth moving
ahead with the site’s involvement in the trial. We also
think that the flags might be a helpful training tool
for new or inexperienced TMs to provide a basic
structure to the discussions they have with sites dur-
ing set-up and at SIVs.
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By the end of the SIV, it may be possible to make a
judgement about recruitment success by looking
across the red flags, combined with any other relevant
information the TM has. The TM could create a
matrix listing all sites and their red flags, which
would give an overview of high-risk sites, those not
expected to recruit to target. The aim, of course,
would be to have mostly low-risk sites, with very
high-risk sites having been excluded before the SIV
or put on hold until one or more red flags change.
That matrix will give the central trial team an indica-
tion of where their limited resources should be
targeted when thinking of sites and recruitment.
Strengths and limitations
There are a number of limitations. First, the work was
done at a single trials unit and involved a relatively small
number of TMs. While clearly a limitation, this work
was the first stage of the project so its limited scale
seems appropriate. Moreover, we expected predictions
to be improved by having red flags and identifying those
flags was part of this work. Now we have those red flags,
further work needs to be on a bigger scale and involve
more trials units and teams. To this end, we have devel-
oped a revised prediction form (see Additional file 2)
and plan to test this further both among TMs based in
CHaRT and across the UK; we ask that TMs who are in-
terested in joining an evaluation of the new prediction
tool get in touch with us. The second limitation was that
the predictions were made after the SIV by which point
much of the TM’s work has already been invested in the
site regardless of the prediction. Again, while true we (1)
had no intention of acting on the predictions because we
had no idea how good they were and (2) we wanted the
red flags to be as well-informed as they could be. After
the SIV therefore seemed the best point at which to
make the prediction. As mentioned earlier in the
‘Discussion’ section, some of our red flags could easily
be considered before the SIV and trial teams could in
principal take action based on their assessments. The
third limitation was that most predictions were made for
face-to-face site initiation visits. It can be argued that it
is easier to build good rapport with sites staff at
face-to-face meetings and there is obviously an oppor-
tunity to pick up on body language cues too. However,
few prediction justifications were based on body lan-
guage rather than actual behaviour and we did not see
signs of behaviour change (e.g. differences in attendance)
due to the mode of the visit, though a larger study may
have seen a difference. Face-to-face SIVs are expensive
in time and money and other modes might be preferred.
Giving TMs red flags to consider, some before the SIV,
may allow decisions about when to use a face-to-face
meeting and when to limit investments in sites by using
other modes..
We think the study also has some strengths. It set out
with the intention of tapping into the experience of TMs
rather than to ask site or trial staff to do substantial
amounts of form-filling. Even in the complete absence of
guidance, a very simple form and TMs’ experience led to
a reasonable first shot at predictions. The qualitative
work, especially the post-results reflection, leave us reas-
sured that the red flags have face-validity. For example,
they map nicely onto the issues listed on the Clinical
Trials Toolkit, a tool to provide practical advice to re-
searchers in designing and conducting publicly funded
clinical trials in the UK (http://www.ct-toolkit.ac.uk/rout
emap/feasibility-and-investigator-selection/). We are
confident that any TM looking at the list in Table 5 will
nod his or her head in weary agreement. Finally, the work
was good fun, captured recruitment intelligence from > 50
site initiation visits and led to a modified but still simple
tool that we plan to test and all without creating a mass of
extra work for TMs.
Conclusions
Poorly recruiting sites soak up considerable time and re-
source in return for a handful of participants. It would be
best for everyone and particularly central trial teams if we
could predict which sites these would be and either fix
things or wave a polite goodbye.
In this small study, we asked 10 TMs to make simple,
unguided Yes/No predictions about site recruitment in
eight trials; they correctly identified 82% of sites that did
hit their recruitment target and 32% of those that did not.
Crucially, the latter—correctly identifying sites that will fail
to recruit—is not good enough for decision-making. How-
ever, the study also provided us with a list of eight red
flags—factors that are linked to poor recruitment—which
we think will make TMs’ future predictions better.
We have developed a modified prediction form includ-
ing these red flags and encourage anyone interested in
contributing to its evaluation to contact us.
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